Genetic markers have been shown to predict a person’s likelihood of developing various types of cancer.

Now, researchers believe that new artificial intelligence (AI) tools could make it easier and faster for doctors to detect those indicators.

A team of neurosurgeons and engineers at the University of Michigan announced last week that their new AI-based diagnostic tool, DeepGlioma, is capable of pinpointing genetic mutations in brain tumors during surgery within just 90 seconds.